Institution identification

PURI

https://redirect.ema.europa.eu/resource/6872

Institution ID

6872

Institution full name and acronym

Health Search, Italian College of General Practicioners

Institution countries

Italy

Type of institution

Educational Institution
Other

Institution website

ENCePP partner

Yes
Institution description
The Italian College of General Practitioners (SIMG) is a scientific society aimed to promote the role of General Practice within the National Health System. The main activities are focused on education and research. Research is mainly developed throughout the Health Search network,based on: (1) a school in which primary care physicians (PCPs) receive training and shares the same standards for recording electronic patients information,(2) a database Health Search/CSD longitudinal patients database (HSD),where PCPs collects patients information. The group working with HSD data is a multidisciplinary team of epidemiologists,statisticians and IT experts,it provides value-added services to: (1) the PCPs who contribute to the HSD,(2) the stakeholders that are interested in using this research tool. Health Search-SIMG is currently involved in several national and multinational research projects on drug safety and drug utilization,HTA and health services research studies.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact

Studies conducted by the institution

ACCESS template protocol for safety of COVID-19 vaccines
An Observational Post-Authorisation Safety Study of Lesinurad Patients (SATURATES)
Drug Utilization Study (DUS) and post authorization safety study (PASS) on the fixed combination Tramadol-Dexketoprofen (DKP-TRAM)
Estimating prevalence and incidence of acute myocardial infarction in a set of heterogeneous sources of observational health data collaborating in the EMIF Platform
EUROPEAN NON-INTERVENTIONAL POST AUTHORIZATION SAFETY STUDY RELATED TO SERIOUS INFECTIONS FOR ROMOSOZUMAB BY THE EU ADR ALLIANCE
EUROPEAN NON-INTERVENTIONAL POST-AUTHORIZATION SAFETY STUDY RELATED TO ADHERENCE TO THE RISK MINIMIZATION MEASURES FOR ROMOSOZUMAB BY THE EU-ADR ALLIANCE
European non-interventional post-authorization safety study related to serious cardiovascular events of myocardial infarction and stroke, and all-cause mortality for romosozumab by the EU-ADR Alliance
Multinational database cohort study to assess RMP specified safety outcomes in association with indacaterol/glycopyrronium bromide in Europe
Safety Evaluation of Adverse Reactions in Diabetes - Comparative studies (SAFEGUARD)
VALIDATION STUDY PROTOCOL (OP0007) FOR THE EUROPEAN NON-INTERVENTIONAL POST- AUTHORIZATION SAFETY STUDY RELATED TO SERIOUS CARDIOVASCULAR EVENTS OF MYOCARDIAL INFARCTION AND STROKE AND ALL-CAUSE MORTALITY FOR ROMOSOZUMAB BY THE EU-ADR ALLIANCE (OP0004) AND EUROPEAN NON-INTERVENTIONAL POST-AUTHORIZATION SAFETY STUDY RELATED TO SERIOUS INFECTIONS FOR ROMOSOZUMAB BY THE EU-ADR ALLIANCE (OP0006)